Overseas Gonorrhea Screening Among Newly Arrived Refugees During 2018.
J Immigr Minor Health
; 23(6): 1354-1358, 2021 Dec.
Article
em En
| MEDLINE
| ID: mdl-34533683
ABSTRACT
We assessed the overseas gonorrhea results reported in the CDC's Electronic Disease Notification (EDN) system among refugees ≥ 15 years old who arrived in the United States during 2018. Of 18,720 refugees, 57 (0.4%) tested positive. Among those with a positive test, 31 (54.5%) were born in the Democratic Republic of the Congo, followed by 12 (21.1%) from Afghanistan. Thirty-three (57.9%) cases were female. Fifty-one cases (89.4%) were between 15 and 44 years of age; 25 (43.9%) were ages 15-24 and 26 (45.6%) were ages 25-44. Among the cases, 56 (98.2%) were treated overseas with the recommended therapy of ceftriaxone and azithromycin. Our findings suggest that the risk of gonorrhea in refugees is similar to that in the U.S. Given recent worldwide increases in gonorrhea, additional monitoring among refugees are necessary to assess the appropriateness of the gonorrhea screening requirement in the overseas medical examination.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Refugiados
/
Gonorreia
/
Emigrantes e Imigrantes
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article